Forma Therapeutics Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $173,986,000.
Profit Margin
| 2018 | 164.09M | 5.29M | 3.23% |
|---|---|---|---|
| 2019 | 100.55M | -34.79M | -34.6% |
| 2020 | 0 | -70.41M | |
| 2021 | 0 | -172.96M |
FMTX Income Statement (2018 – 2021)
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 100.55M | 164.09M |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 100.55M | 164.09M |
Operating exp. | ||||
Research and development | 125.66M | 93.36M | 111.31M | 132.85M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 173.98M | 124.14M | 135.71M | 154.39M |
Operating income | -172.81M | -124.21M | -40.45M | 9.69M |
Other income (expenses), net | 174.14M | 24.07M | 3.80M | 4.16M |
Income before tax | -172.81M | -100.13M | -36.64M | 13.86M |
Income tax expense | 154K | -29.71M | -1.84M | 8.56M |
Net income | -172.96M | -70.41M | -34.79M | 5.29M |
Earnings per share | ||||
Basic EPS | -4.21 | -3.05 | -3.06 | 0.47 |
Diluted EPS | -4.21 | -3.05 | -3.06 | 0.47 |
| Data source | Data source |